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The  HLA-D/DR  region  codes  for  the  human  class  II  antigens  that  play 
important roles in many immune phenomena (1).  At the Eighth International 
Histocompatibility Workshop, 12 D specificities defined by the mixed lymphocyte 
reaction  and  10  DR  specificities defined by  the  microcytotoxicity test  using 
alloantisera  have  been  approved  (2).  The  DR  specificity correlates  to  the  D 
specificity for the most part, but there are some populations that have the same 
DR specificity but different D specificities. In the DR4 population, there are at 
least six D specificities (Dw4, Dwl0,  DYT, DKT2, DB3, and LD40) (3, 4).  On 
the other hand, it has been shown that there are at least three kinds of human 
class  II molecules, DR, DC(MB), and SB antigens (5-7).  Furthermore, we have 
demonstrated that the MT3 molecule exists independently of the DR molecule 
in a  DR4  homozygous cell line and that the MT3  antigen may belong to the 
fourth  group  of human  class  II  antigen,  distinct  from  the  DR,  DC,  and  SB 
antigens (8).  It is important to clarify which class  II molecules are involved in 
the dissection of the D  specificity. In the analysis of the relationship between 
HLA-D and class II molecules, we must consider not only the DR molecule but 
also the other class II molecules of which specificities are closely linked to HLA- 
DR. In fact, Zeevi et al. (9) have already prepared the primed lymphocyte typing 
(PLT) clones whose specificities are associated with DR4,  MB3, or MT3,  using 
DR4-positive cells for the stimulator. In addition, it has been shown that three 
D  specificities (Dw4,  DKT2,  DYT)  can  be  distinguished by  their differential 
reactivities against two kinds of monoclonal antibodies that seem to recognize 
the determinants on  the  MB3  molecule (10,  11),  suggesting that  the class  II 
molecule coded for by the  DC  locus also  relates to  the differences in  the  D 
specificities. It has also been reported, using monoclonal antibodies against a DR 
monomorphic determinant and two-dimensional (2-D) ~ gel electrophoresis, that 
the DR light chain showed a structural polymorphism among the DR4 homozy- 
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gous cell lines and that the polymorphism correlated with the differences of the 
D specificities (12, 13), though it was not confirmed in these studies whether the 
class  II  molecule  recognized  by  the  monoclonai  antibodies  carried  the  DR4 
alloantigenic determinant defined serologically. On the other hand, it is not yet 
clear  whether  the  MT3  molecule show a  structural  polymorphism  among  the 
DR4 homozygous cell lines with different D types. 
In this paper, to analyze which class II molecules mainly cause the dissection 
of the D  specificity among Dw4, DKT2, and  DYT, we identify the major class 
II  antigens  and  compare  qualitatively  and  quantitatively  among  the  cell  lines 
with different D specificities by 2-D gel electrophoresis and alloantisera. 
Materials and Methods 
Cell Lines and Culture.  Epstein-Barr virus transformed B lymphoid cell lines Wa (HLA- 
Aw24/Aw24, Bw54/Bw54, DYT/DYT, DR4/DR4, MT3/MT3), L-KT13 (HLA-Aw24/ 
Aw31, Bw51/B7, DKT2/DKT2, DR4/DR4, MT3/MT3), and ER (HLA-A2/A2, Bw44/ 
Bw44, Dw4/Dw4, DR4/DR4, MT3/MT3) were kind gifts from Dr. A. Wakisaka,  Hok- 
kaido  University,  Sapporo, Dr.  N. Kashiwagi, Kitasato  University,  Sagamihara,  and Dr. 
T. Sasazuki, Tokyo Medical and Dental  University,  Tokyo, respectively.  All cells were 
maintained  at 2-10 ×  105 cells/ml  in RPMI 1640 medium (Gibco Laboratories, Grand 
Island, NY) supplemented with 10% heat-inactivated  fetal bovine serum. 
Antisera.  Alloantisera 070402 (anti-DR4), DKA05 (anti-DR4), and DKA11 (anti-MT3) 
were purchased from Hoechst Japan  Co.,  Tokyo. AIloantisera  TD148 (anti-MT3)  and 
S19 (anti-MT3)  were kind gifts from Dr.  H. Maeda,  Tokyo University  Hospital,  Tokyo 
and from Saitama  Blood Center, Japan Red Cross, Saitama, respectively.  Ailoantiserum 
T2297 (anti-DR4)  was obtained from the Blood Transfusion Service, Tokyo Women's 
Medical College. 
Purification  of Membrane Glycoproteins and Labeling.  The membrane glycoprotein was 
purified as described previously  (14,  15). Briefly, the membrane from 2-6 x  109 cells 
were solubilized  with  1%  Nonidet  P-40  in  0.15  M  NaCI,  20  mM  Tris-HC1,  pH  7.8. 
Glycoproteins were purified from the membrane fraction by lentil lectin chromatography. 
A small portion of the glycoproteins was labeled with t2~I by the chloramine T method. 
Immunoprecipitation  and 2oD Gel Electrophoresis.  Immunoprecipitation was performed 
as described previously  (16). Briefly, 5-I 0 #1 labeled glycoproteins were incubated with 
30 #1 alloantisera  at 4°C overnight. Then 20 ~1 protein A-Sepharose CL-4B was added to 
the reaction mixture. The antigen-antibody complex thus isolated was analyzed  by 2-D 
gel electrophoresis,  performed as described previously (17). The l~SI-labeled glycoproteins 
were detected on  the  2-D  gel  by autoradiography  and  unlabeled glycoproteins were 
detected by Coomassie Brilliant Blue staining. 
Results 
To reveal the quantitative and qualitative differences of the class II antigens 
expressed on B cells, we first analyzed and compared the membrane glycoproteins 
from  three  DR4  homozygous cell  lines  with  different  D  types (Dw4,  DKT2, 
DYT) by 2-D gel electrophoresis and Coomassie Brilliant Blue staining.  Fig.  1 B 
and C show that  under these conditions,  one heavy chain (HI) and two sets of 
light  chains  of class  II-iike  molecules are  detected in  ER (Dw4) and  L-KT13 
(DKT2) cells. There is a large difference in the amounts of the two different sets 
of the light chains.  We tentatively designated the set of light chains in a  larger 
amount, L1, and the set of the light chains in a lesser amount, L2. In Wa (DYT) 
cells, only one set of heavy and light chains (H1, L1) is detected (Fig.  1A).  This 
result is probably due to less expression of L2 in Wa cells than in the other two SUZUKI  ET  AL.  753 
FIGURE  1.  2-D gel analysis of the membrane glycoproteins from Wa (DYT) (A), ER (Dw4) 
(B), and L-KT13 (DKT2) (C) cells.  Approximately  150 #g of the membrane glycoproteins 
from  Wa and  ER  and about  200  #g of the membrane glycoproteins from  L-KTI3 were 
subjected to the electrophoresis. Spots were detected by Coomassie Brilliant Blue staining. 
The basic end of the NEPHGE gel is on the left and the direction of sodium dodecyl sulfate- 
polyacrylamide gel electrophoresis is  from  top to  bottom.  The portion of the gels shown 
corresponds to the region between 25,000 and 50,000 daltons. 
cell  lines.  The  comparison of the  2-D  gel pattern  among the  three cell  lines 
revealed that the electrophoretic mobility of L 1 is different from one another. 
The pI of L 1 from Wa (DYT) is the most basic, followed in order by those from 
ER (Dw4) and L-KT 13 (DKT2). On the contrary, significant differences in the 
electrophoretic mobilities are not observed between L2 from ER and L-KT13 
and among the heavy chains (H 1) from the three cell lines. 
To clarify what alloantigenic determinants reside in these two sets of class II- 
like  molecules,  the  125I-labeled  membrane glycoproteins from  these cell  lines 
were precipitated  with  three  kinds of anti-DR4  typing alloantisera  and  three 
kinds  of anti-MT3  alloantisera.  Fig.  2A  shows  the  2-D  gel  pattern  of the 
precipitates with anti-DR4  alloantiserum  T2297  from Wa,  ER,  and  L-KT13. 
The anti-DR4 alloantiserum T2297  precipitates only one set each of heavy and 
light chains in  these cell lines.  The other two anti-DR4  alloantisera (070402, 754  MT3  AND  DR4  MOLECULES  FROM  DIFFERENT  D-TYPED  CELLS 
DKA05) also precipitated the same heavy and light chains. In contrast, normal 
human serum did not precipitate these heavy and light chains (data not shown). 
Therefore, these heavy and light chains are considered the DR4 heavy and light 
chains in each cell line. Although the heavy chains of the DR4 molecules from 
these three cell lines show the same electrophoretic mobility, the relative position 
of the light chain of the DR4 molecules are different from one another among 
the three cell lines. The pI of the DR4 light chain from Wa (DYT) is the most 
basic, and that from L-KT13 (DKT2), the most acidic. Since the electrophoretic 
mobility of the DR4 light chain in Fig.  2A and of L1  in Fig.  1 are identical in 
each of the three cell lines, L 1 is considered the DR4 light chain. 
Fig. 2B shows the 2-D gel pattern of the precipitates with anti-MT3 alloanti- 
serum TD148  from Wa,  ER, and L-KT13.  The heavy chain precipitated with 
TD148  is  indistinguishable  from the  DR  heavy chain  in  the  three  cell  lines. 
Minor light chain spots in Wa and L-KT13 in Fig. 2B show the same electropho- 
retic mobility as that of the DR4  light chain in Fig.  2A in each cell line.  The 
minor spots are considered to represent the DR4 light chains which are precipi- 
tated with a  contaminated antibody against DR4.  We have already shown  (8) 
that anti-MT3 alloantisera often contain the antibody against DR and that the 
DR4 molecule does not carry the MT3 antigenic determinant. The major light 
FIGURE 2.  2-D gel analysis of the immunoprecipitated DR4 (A) and MT3 (B) molecules from 
Wa  (DYT),  ER  (Dw4),  and  L-KT13  (DKT2)  cells,  l~SI-labeled  membrane  glycoproteins 
precipitated with anti-DR4 alloantiserum (T2297) (A) and anti-MT3 alloantiserum (TD148) 
(B). The  upward arrowhead  indicates the  DR4 heavy chain and the downward arrowheads 
show the DR4 light chain. The upward and downward arrows indicate the MT3 heavy and 
light chains, respectively. Gel orientation is the same as in Fig. 1. SUZUKI ET  AL:  755 
chain precipitated with TD148 is different from the DR4 light chain in each of 
Wa and L-KT 13 cells. TD 148 precipitates only one set of heavy and light chain 
in ER cells and the light chain is distinct from the DR4 light chain. To illustrate 
the difference in the relative position of the MT3 alloantisera-specific light chain 
and the DR4 light chain in ER cells, the 2-D gel pattern of the precipitate with 
DKA11  (anti-MT3)  from this cell line is presented in Fig.  3B, because DKA11 
precipitates a small amount of the DR4 light chain in addition to the same heavy 
and light chains precipitated  with TD 148. Furthermore,  the mixed experiment 
shows that the MT3 alloantisera-specific light chains from these three cell lines 
are  indistinguishable  from  one another  (Fig.  3A).  We have  already shown  (8) 
that the heavy chain and the MT3 alloantisera-specific light chain precipitated 
with  TD148  are the  components of the  MT3  molecule in  Wa cells.  Since  the 
heavy  chain  and  the  MT3  alloantisera-specific  light  chain  precipitated  with 
TD148  from  ER and  L-KT13  cells are  identical  to  the  MT3  heavy and  light 
chains  of Wa cells,  these  heavy and  light  chains  are components  of the  MT3 
molecule in ER and L-KT 13 cells. The other two anti-MT3 alloantisera (DKA 11, 
S 19) gave the same results.  These data indicate that  the three cell lines possess 
the same MT3 molecule, which consists of a heavy chain indistinguishable  from 
the  DR heavy chain  and  the light  chain  specific for the MT3.  Since the  MT3 
light  chain  and  L2  in  Fig.  1  show  the  same  electrophoretic  mobility,  L2  are 
considered the MT3 light chains in ER and L-KT13 cells. These results indicate 
FIGURE 3.  (A) Comparison of the MT3 molecules  from Dw4, DKT2, and DYT homozygous 
cell lines. One third of TD 148 immunoprecipitates from Wa (DYT), ER (Dw4),  and L-KT  1  g 
(DKT2) were mixed and coelectrophoresed. (B) 2-D gel analysis of the immunoprecipitate 
with DKA11 (anti-MT3) from ER (Dw4)  cells. The indication and gel orientation are the same 
as in Fig.  2. 756  MT3  AND  DR4  MOLECULES  FROM  DIFFERENT  D-TYPED  CELLS 
that the MT3 molecule is less expressed than the DR4 molecule on the three cell 
lines. 
Discussion 
The D specificity is likely to be decided by the sum of the differences of class 
II molecules. To decide which class  II molecule mainly causes the dissection of 
the D  specificity, we must analyze both  the qualitative  differences of class  II 
antigens  among  the  cells  with  different  D  specificities  and  the  quantitative 
differences of the class II molecules in each cell. In this paper, we have demon- 
strated directly, using 2-D gel electrophoresis and anti-DR4 alloantisera, that the 
light  chains  that  carry the  DR4  alloantigenic determinant  show  a  structural 
polymorphism among the DR4 homozygous cell lines with different D specificities 
(Dw4,  DKT2,  DYT)  (Fig.  2A).  We  have  also  shown,  by  the  electrophoretic 
analysis of the membrane glycoproteins, that  most of the class  II light chains 
consist of the DR light chain (Fig.  1). On the contrary, both the heavy and light 
chains of the MT3 molecules are identical among the DR4 homozygous cell lines 
with  the different D  specificities (Figs.  2B,  3).  Even if the class  II  molecules 
encoded by the DC locus are different from one another among the three cell 
lines, the differences seem to play only a  minor role in the dissection of the D 
specificity, because the DC locus product expresses little compared with the DR 
locus product (Fig. 1). These results indicate that the dissection of the D specificity 
among Dw4, DKT2, and DYT is mainly caused by the differences of the DR4 
molecules and that the MT3 molecule does not participate in the dissection. 
We have shown in a previous paper (8) and in this paper that the light chain 
of the MT3  molecule is specific for the MT3 but that the heavy chain of the 
MT3  molecule is indistinguishable from that of the DR.  We have also shown 
that three different DR4 homozygous cell lines with different D specificities have 
the identical MT3 molecule. Furthermore, our recent data (manuscript submit- 
ted for publication) show no electrophoretic heterogeneity in the MT3 molecule 
among the DR4,  DR7,  and DRw9  homozygous cell lines.  These observations 
suggest  that  the  MT3  molecule has  no  structural  polymorphism among  the 
DR4-,  DR7-,  and DRwO-positive populations.  On the other hand,  the class  II 
molecules carrying other supertypic specificities (MB1,  MB3) show both serol- 
ogical and structural polymorphisrns (7, 11,  18, 19). Our recent analysis (unpub- 
lished data) of the MT2 molecule from DR3,  5,  w6, and w8 homozygous cells 
by 2-D gel electrophoresis also suggets that the MT2  molecule is structurally 
polymorphic. The  frequencies of the  MT3  antigen are 0.600  in  the oriental 
population and 0.401  in the Caucasian population (20).  If the MT3 molecules 
have no heterogeneity at the population  level, the MT3 antigen is one of the 
most common specificities among the class II antigen specificities. These findings 
may indicate that the MT3 gene is the prototype of the genes of the human class 
II antigens. 
Summary 
This report demonstrates directly, using two-dimensional gel electrophoresis 
and  alloantisera,  the  following:  (a)  The  DR4  light  chains  show  a  structural SUZUKI  ET  AL.  757 
polymorphism among the Dw4,  DKT2, and DYT cells. (b) Most of the class II 
light chains consist of the DR light chain. (c) The MT3 molecule is distinct from 
the DR4  molecule in the Dw4,  DKT2, and DYT cells. (d) The MT3  molecule 
does not show any structural heterogeneity among the Dw4, DKT2, and DYT 
cells. These results suggest that the dissection of the D  specificity among Dw4, 
DKT2, and DYT is mainly caused by the differences of the DR4 molecules. 
Received  for publication  13 February 1984. 
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